Federated Hermes, Inc. Cytokinetics Inc Transaction History

Federated Hermes, Inc.

$43 Billion
Q4 2024

A detailed history of Federated Hermes, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 37,101 shares of CYTK stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,101

Previous 33,555 10.57%

Holding current value

$1.62 Million

Previous $1.77 Million 1.47%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$46.36 - $58.62 $164,392 - $207,866	3,546 Added 10.57%	37,101 $1.75 Million
Q3 2024 Nov 13, 2024	BUY	$51.22 - $60.16 $381,947 - $448,613	7,457 Added 28.57%	33,555 $1.77 Million
Q2 2024 Aug 08, 2024	BUY	$47.86 - $75.05 $838,985 - $1.32 Million	17,530 Added 204.6%	26,098 $1.41 Million
Q1 2024 May 14, 2024	BUY	$63.75 - $108.06 $546,210 - $925,858	8,568 New	8,568 $600,000
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $5.88 Million - $8.41 Million	164,494 Added 2741566.75%	164,500 $7.54 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $231 - $327	6 New	6 $1,000
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $7.29 Million - $11.3 Million	-245,198 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $8.42 Million - $11.4 Million	245,198 New	245,198 $11.2 Million
Q4 2020 Feb 12, 2021	SELL	$15.26 - $28.61 $5,310 - $9,956	-348 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$20.58 - $28.96 $687,433 - $967,350	-33,403 Reduced 98.97%	348 $8,000
Q2 2020 Aug 13, 2020	BUY	$11.15 - $24.64 $351,526 - $776,825	31,527 Added 1417.58%	33,751 $796,000
Q1 2020 May 13, 2020	SELL	$8.75 - $16.3 $827,225 - $1.54 Million	-94,540 Reduced 97.7%	2,224 $26,000
Q4 2019 Feb 14, 2020	SELL	$7.95 - $11.84 $6.63 Million - $9.88 Million	-834,163 Reduced 89.61%	96,764 $1.03 Million
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $9.84 Million - $13 Million	909,472 Added 4238.97%	930,927 $10.6 Million
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $159,031 - $225,045	20,004 Added 1378.64%	21,455 $241,000
Q1 2019 May 10, 2019	BUY	$5.95 - $10.19 $3,528 - $6,042	593 Added 69.11%	1,451 $12,000
Q4 2018 Feb 13, 2019	BUY	$5.91 - $9.29 $2,216 - $3,483	375 Added 77.64%	858 $5,000
Q1 2018 May 09, 2018	SELL	$7.2 - $10.05 $11,376 - $15,879	-1,580 Reduced 76.59%	483 $3,000
Q4 2017 Feb 14, 2018	BUY	$7.25 - $15.65 $11,455 - $24,727	1,580 Added 327.12%	2,063 $0
Q3 2017 Nov 13, 2017	BUY	$12.0 - $15.0 $5,796 - $7,245	483	483 $7,000

Others Institutions Holding CYTK

# of Institutions

396

Shares Held

114M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.11B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Cytokinetics Inc Transaction History